Proteomics in Nephrology - Towards Clinical ApplicationsAvailable to Purchase
Since the publication of the first volume on proteomics in nephrology, methodologies and protocols for renal and urinary proteome analyses have been continuously improved, resulting in considerable progress towards clinical application. Proteomics not only contributes to a better understanding of the renal physiology and pathogenic mechanisms of kidney diseases, but also assists in the search for novel biomarkers for diagnostics and prognostics and supports the definition and development of new therapeutic targets and drugs for better therapeutic outcome. While the first volume focused mainly on an overview, technologies and methodologies, this volume highlights successful applications of proteomics to several kidney diseases, including acute kidney injury, nephrotic syndrome, diabetic nephropathy, renal allograft rejection, renal cell carcinoma, obstructive nephropathy, kidney stone disease, uremia, and others. Written by acclaimed experts in proteomics and nephrology, this book is an excellent resource of references for nephrologists, clinicians, pharmacists, other healthcare professionals, proteomists, physiologists, scientists, and trainees.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 16: Proteomics for the Investigation of Acute Kidney InjuryByPrasad DevarajanPrasad DevarajanNephrology and Hypertension, Cincinnati Children’s Hospital Medical Center,University of Cincinnati, Cincinnati, Ohio, USASearch for other works by this author on:
-
17 - 28: Proteomics of Plasma and Urine in Primary Nephrotic Syndrome in ChildrenByGiovanni Candiano;Giovanni CandianoaLaboratory on Pathophysiology of Uremia,Search for other works by this author on:Luca Musante;Luca MusanteaLaboratory on Pathophysiology of Uremia,dRenal Child Foundation, Genoa,Search for other works by this author on:Andrea Petretto;Andrea PetrettobMass Spectrometry Core Facility,Search for other works by this author on:Maurizio Bruschi;Maurizio BruschiaLaboratory on Pathophysiology of Uremia,dRenal Child Foundation, Genoa,Search for other works by this author on:Laura Santucci;Laura SantucciaLaboratory on Pathophysiology of Uremia,dRenal Child Foundation, Genoa,Search for other works by this author on:Andrea Urbani;Andrea UrbanieIRCCS-Fondazione Santa Lucia, Rome,Search for other works by this author on:Francesco Scolari;Francesco ScolarigDepartment of Nephrology, University of Bescia, Brescia, Italy;Search for other works by this author on:Rosanna Gusmano;Rosanna GusmanodRenal Child Foundation, Genoa,Search for other works by this author on:Michele Carraro;Michele CarrarofDepartment of Nephrology, University of Trieste, Trieste,Search for other works by this author on:Cristina Zennaro;Cristina ZennarodRenal Child Foundation, Genoa,Search for other works by this author on:Flavio Vincenti;Flavio VincentihTransplant Service, University of California, San Francisco, Calif., USASearch for other works by this author on:Gian Marco GhiggeriGian Marco GhiggeriaLaboratory on Pathophysiology of Uremia,Search for other works by this author on:
-
29 - 36: Urinary Proteome Profiling to Search for Biomarkers in Steroid-Resistant Nephrotic SyndromeByAvram Z. Traum;Avram Z. TraumaPediatric Nephrology Unit, Massachusetts General Hospital,cHarvard Medical School, Boston, Mass., USASearch for other works by this author on:Asher D. SchachterAsher D. SchachterbDivision of Nephrology and Children’s Hospital Informatics Program, Children’s Hospital Boston, andcHarvard Medical School, Boston, Mass., USASearch for other works by this author on:
-
37 - 52: Searching for Novel Biomarkers and NewTherapeutic Targets of Diabetic Nephropathy Using Proteomics ApproachesByVisith ThongboonkerdVisith ThongboonkerdMedical Proteomics Unit and Medical Molecular Biology Unit,Office for Research and Development, Faculty of Medicine Siriraj Hospital,Mahidol University, Bangkok, ThailandSearch for other works by this author on:
-
53 - 64: Diagnostic and Prognostic Biomarkers in Acute Renal FailureByJohn M. Arthur;John M. ArthurRalph H. Johnson VA Medical Center and Medical University of South Carolina,Charleston, S.C., and University of Texas MD Anderson Cancer Center, Houston,Tex., USASearch for other works by this author on:Michael G. Janech;Michael G. JanechRalph H. Johnson VA Medical Center and Medical University of South Carolina,Charleston, S.C., and University of Texas MD Anderson Cancer Center, Houston,Tex., USASearch for other works by this author on:Sanju A. Varghese;Sanju A. VargheseRalph H. Johnson VA Medical Center and Medical University of South Carolina,Charleston, S.C., and University of Texas MD Anderson Cancer Center, Houston,Tex., USASearch for other works by this author on:Jonas S. Almeida;Jonas S. AlmeidaRalph H. Johnson VA Medical Center and Medical University of South Carolina,Charleston, S.C., and University of Texas MD Anderson Cancer Center, Houston,Tex., USASearch for other works by this author on:T. Brian PowellT. Brian PowellRalph H. Johnson VA Medical Center and Medical University of South Carolina,Charleston, S.C., and University of Texas MD Anderson Cancer Center, Houston,Tex., USASearch for other works by this author on:
-
65 - 75: Proteomics and Renal Transplantation: Searching for Novel Biomarkers and Therapeutic TargetsByStefan Schaub;Stefan SchaubaDepartment for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland;Search for other works by this author on:John A. Wilkins;John A. WilkinsbSections of Biomedical Proteomic and Rheumatology, Manitoba Centre for Proteomics and Systems Biology, Faculty of Medicine, University of Manitoba, Winnipeg, Man., CanadaSearch for other works by this author on:Peter NickersonPeter NickersonbSections of Biomedical Proteomic and Rheumatology, Manitoba Centre for Proteomics and Systems Biology, Faculty of Medicine, University of Manitoba, Winnipeg, Man., CanadaSearch for other works by this author on:
-
76 - 87: Metabolomics: A Complementary Tool in Renal TransplantationByDavid S. WishartDavid S. WishartDepartments of Biological Sciences and Computing Science, University of Alberta,National Research Council, National Institute for Nanotechnology, Edmonton, Alta.,CanadaSearch for other works by this author on:
-
88 - 106: Understanding and Managing Renal Cell Carcinoma: Can Proteomic Studies Contribute to Clinical Practice?ByRachel A. Craven;Rachel A. CravenCancer Research UK Clinical Centre, St James’s University Hospital, Leeds, UKSearch for other works by this author on:Rosamonde E. BanksRosamonde E. BanksCancer Research UK Clinical Centre, St James’s University Hospital, Leeds, UKSearch for other works by this author on:
-
107 - 126: Capillary Electrophoresis Coupled to Mass Spectrometry for Biomarker Discovery and Diagnosis of Kidney DiseasesByPetra Zürbig;Petra ZürbigMosaiques Diagnostics and Therapeutics AG, Hannover, GermanySearch for other works by this author on:Harald MischakHarald MischakMosaiques Diagnostics and Therapeutics AG, Hannover, GermanySearch for other works by this author on:
-
127 - 141: Identification of Urinary Biomarkers by Proteomics in Newborns: Use in Obstructive NephropathyByStephane Decramer;Stephane DecrameraInserm, U858;b Université Toulouse III Paul Sabatier, IFR31, Institut Louis Bugnard, andc CHU de Toulouse, Nephropediatric Unit, Hôpital des Enfants, TSA 70034, Toulouse, France;Search for other works by this author on:Petra Zürbig;Petra Zürbigd Mosaiques Diagnostics and Therapeutics AG, Hannover, GermanySearch for other works by this author on:Stefan Wittke;Stefan Wittked Mosaiques Diagnostics and Therapeutics AG, Hannover, GermanySearch for other works by this author on:Harald Mischak;Harald Mischakd Mosaiques Diagnostics and Therapeutics AG, Hannover, GermanySearch for other works by this author on:Jean-Loup Bascands;Jean-Loup BascandsaInserm, U858;b Université Toulouse III Paul Sabatier, IFR31, Institut Louis Bugnard, andSearch for other works by this author on:Joost P. SchanstraJoost P. SchanstraaInserm, U858;b Université Toulouse III Paul Sabatier, IFR31, Institut Louis Bugnard, andSearch for other works by this author on:
-
142 - 158: Proteomics and Kidney Stone DiseaseByVisith ThongboonkerdVisith ThongboonkerdMedical Proteomics Unit & Medical Molecular Biology Unit,Office for Research and Development, Faculty of Medicine Siriraj Hospital,Mahidol University, Bangkok, ThailandSearch for other works by this author on:
-
159 - 171: Exploring the Uremic Toxins Using Proteomic TechnologiesByEric Schiffer;Eric SchifferaMosaiques Diagnostics & Therapeutics, Hanover;Search for other works by this author on:Harald Mischak;Harald MischakaMosaiques Diagnostics & Therapeutics, Hanover;b Hanover Medical School, Hanover, Germany, andSearch for other works by this author on:Raymond C. VanholderRaymond C. Vanholderc Nephrology Section, Department of Internal Medicine, University Hospital, Gent, BelgiumSearch for other works by this author on:
-
172 - 185: Proteomic Approaches for the Study of Cell Signaling in the Renal Collecting DuctByEwout J. Hoorn;Ewout J. HoornLaboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:Trairak Pisitkun;Trairak PisitkunLaboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:Ming-Jiun Yu;Ming-Jiun YuLaboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:Mark A. KnepperMark A. KnepperLaboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:
-
186 - 197: Overview of Kidney and Urine Proteome DatabasesByYutaka Yoshida;Yutaka YoshidaaDepartment of Structural Pathology, Institute of Nephrology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, andSearch for other works by this author on:Masahito Miyamoto;Masahito MiyamotoaDepartment of Structural Pathology, Institute of Nephrology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, andb Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JapanSearch for other works by this author on:Xu Bo;Xu BoaDepartment of Structural Pathology, Institute of Nephrology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, andSearch for other works by this author on:Eishin Yaoita;Eishin YaoitaaDepartment of Structural Pathology, Institute of Nephrology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, andSearch for other works by this author on:Tadashi YamamotoTadashi YamamotoaDepartment of Structural Pathology, Institute of Nephrology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, andSearch for other works by this author on: